Insider Trading disclosures for Biodesix Inc

The latest disclosure was made by Scott Hutton in Biodesix Inc where a trade of 387,500 Restricted Stock Units done was reported to US exchanges on Feb. 20, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Scott Hutton	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	387,500	387,500	-		-	Restricted Stock Units
Hutton Scott	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	775,000	775,000	-		-	Stock Options (Right to buy)
Christopher Vazquez	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	39,664	39,664	-		-	Stock Options (Right to buy)
Robin Harper Cowie	CFO, Secy & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	117,500	117,500	-		-	Restricted Stock Units
Christopher Vazquez	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	90,100	90,100	-		-	Stock Options (Right to buy)
Gary Pestano	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	3,810	3,810	-		-	Stock Options (Right to buy)
O’Kane Kieran	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	235,000	235,000	-		-	Stock Options (Right to buy)
Kieran O’Kane	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	87,319	87,319	-		-	Stock Options (Right to buy)
Robin Harper Cowie	CFO, Secy & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	73,398	73,398	-		-	Stock Options (Right to buy)
Robin Harper Cowie	CFO, Secy & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	235,000	235,000	-		-	Stock Options (Right to buy)
Vazquez Christopher	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	45,050	45,050	-		-	Restricted Stock Units
Gary Pestano	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	244,400	244,400	-		-	Stock Options (Right to buy)
O’Kane Kieran	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	117,500	117,500	-		-	Restricted Stock Units
Pestano Gary	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	122,200	122,200	-		-	Restricted Stock Units
Scott Hutton	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	425,929	425,929	-		-	Stock Options (Right to buy)
Scott Hutton	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	52,656	157,969	-		-	Restricted Stock Units
Scott Hutton	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	252,628	785,607	-		-	Common Stock
Scott Hutton	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 0.92 per share.	10 Feb 2025	83,660	701,947	-	0.9	77,319	Common Stock
Scott Hutton	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	12,212	48,848	-		-	Restricted Stock Units
Scott Hutton	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	187,760	375,521	-		-	Restricted Stock Units
Robin Harper Cowie	CFO, Secy & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	67,788	271,124	-		-	Common Stock
Robin Harper Cowie	CFO, Secy & Treasurer	Sale of securities on an exchange or to another person at price $ 0.92 per share.	10 Feb 2025	24,664	246,460	-	0.9	22,794	Common Stock
Robin Harper Cowie	CFO, Secy & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	3,157	12,627	-		-	Restricted Stock Units
Robin Harper Cowie	CFO, Secy & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	48,536	97,070	-		-	Restricted Stock Units
Robin Harper Cowie	CFO, Secy & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	16,095	48,286	-		-	Restricted Stock Units
Kieran O’Kane	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	48,118	145,566	-		-	Common Stock
Kieran O’Kane	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 0.92 per share.	10 Feb 2025	17,527	128,039	-	0.9	16,198	Common Stock
Kieran O’Kane	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	1,489	5,958	-		-	Restricted Stock Units
Kieran O’Kane	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	30,534	61,067	-		-	Restricted Stock Units
Kieran O’Kane	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	16,095	48,286	-		-	Restricted Stock Units
Gary Pestano	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	45,729	172,756	-		-	Common Stock
Gary Pestano	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 0.92 per share.	10 Feb 2025	16,748	156,008	-	0.9	15,479	Common Stock
Gary Pestano	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	1,378	5,513	-		-	Restricted Stock Units
Gary Pestano	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	28,256	56,510	-		-	Restricted Stock Units
Gary Pestano	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	16,095	48,286	-		-	Restricted Stock Units
Christopher Vazquez	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	9,666	21,253	-		-	Common Stock
Christopher Vazquez	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 0.92 per share.	10 Feb 2025	3,630	17,623	-	0.9	3,355	Common Stock
Christopher Vazquez	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	601	2,407	-		-	Restricted Stock Units
Christopher Vazquez	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	4,694	9,388	-		-	Restricted Stock Units
Christopher Vazquez	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2025	4,371	13,112	-		-	Restricted Stock Units
Jack W. Schuler	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 1.23 per share.	21 Nov 2024	100,000	31,194,935	-	1.2	122,840	Common Stock
Lawrence T. Kennedy	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 1.16 per share.	21 Nov 2024	35,000	10,411,024	-	1.2	40,562	Common Stock
Jack W. Schuler	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 1.17 per share.	20 Nov 2024	200,000	31,094,935	-	1.2	234,000	Common Stock
Scott Hutton	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Nov 2024	12,212	61,060	-		-	Restricted Stock Units
Scott Hutton	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Nov 2024	12,212	536,719	-		-	Common Stock
Scott Hutton	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 1.39 per share.	08 Nov 2024	1,927	534,792	-	1.4	2,680	Common Stock
Scott Hutton	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 1.40 per share.	08 Nov 2024	1,813	532,979	-	1.4	2,540	Common Stock
Robin Harper Cowie	CFO, Secy & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Nov 2024	3,156	204,307	-		-	Common Stock
Robin Harper Cowie	CFO, Secy & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Nov 2024	3,156	15,784	-		-	Restricted Stock Units
Robin Harper Cowie	CFO, Secy & Treasurer	Sale of securities on an exchange or to another person at price $ 1.40 per share.	08 Nov 2024	471	203,336	-	1.4	660	Common Stock

Showing 1 to 50 of 500 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

58.33% Fall from 52W High

Insider Trading disclosures for Biodesix Inc

The latest disclosure was made by Scott Hutton in Biodesix Inc where a trade of 387,500 Restricted Stock Units done was reported to US exchanges on Feb. 20, 2025.

Screeners based on Insider Trading and SAST parameters